The Medical Device Clinical Trials Software Market size is valued at USD 1,408.9 illion in 2021 and expected to grow at a CAGR of 14.7% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Medical Device Clinical Trials Software market and that can be segmented by type of delivery, by software type, and end-user. By Type of Delivery, The medical device clinical trials software market has been segmented into Web-based, Cloud-based, and On-premises. The web-based segment is likely to be the largest and fastest-growing segment in terms of type. Based on end-user the medical device clinical trials software market is segmented into Contract Research Organizations (CROs), Medical Device Manufacturers, and Others. Among these, the contract research organizations (cros) segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to Precision Business Insights.
In December 2021, Optimapharm, a leading European clinical research organization, acquired SSS International. This acquisition helped the company is widening its portfolio of clinical research studies.